Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-08-12Clinical Trial Update: Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection [Phase 2]
A Phase 2 study evaluating Imdusiran (AB-729) with intermittent Durvalumab dosing in chronic hepatitis B subjects has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection [Phase 3]
The document provides an update on the efficacy and safety of Peginterferon Alfacon-2 in a Phase 3 study for chronic hepatitis B, which has …
-
CLINICAL_TRIALS withdrawal · 2024-08-06Clinical Trial Update: Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates [Phase 2]
A Phase 2 study evaluating the use of hepatitis B virus NAT-positive donors for hepatitis B-vaccinated lung transplant candidates has been w…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Impact of Fatty Liver on Hepatitis B Therapy
The trial assesses whether fatty liver disease influences hepatitis B antiviral therapy. It is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial evaluating the combination of JNJ-73763989 and JNJ-56136379 with a nucleos(t)ide analog versus a nucleos(t)ide analog alone in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
The trial investigates how liver fibrosis affects hepatic steatosis in chronic hepatitis B using ultrasound attenuation imaging.
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
This clinical trial update describes a real-world study to stage and grade the clinical immune status in chronic hepatitis B and is currentl…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Study on New Strategies for Hepatitis B Virus Immunization [NA]
This clinical trial update notes completion of a study exploring new strategies for Hepatitis B vaccination.
-
EMA approval · 2024-07-24EMA Authorised: Entecavir Accord (Entecavir) — Accord Healthcare S.L.U.
The EMA authorised Entecavir Accord (entecavir) for chronic hepatitis B, confirming a generic entecavir product is now approved in the EU.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Antiviral Therapy in Infants With HBV Infection [Phase 4]
Phase 4 antiviral therapy trial for hepatitis B infection in infants. The study status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection [Phase 1]
Phase 1 trial (NCT06159062) of 162 participants with chronic hepatitis B infection sponsored by Yangshengtang Co., Ltd was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients [Phase 2]
Phase 2 clinical trial evaluating Hepalatide in combination with TAF and PEG-IFN as a finite treatment for chronic hepatitis B has completed…
-
CLINICAL_TRIALS withdrawal · 2024-07-11Clinical Trial Update: Evaluation of the Effectiveness of the Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate in the Adjuvant Therapy of Chronic Hepatitis D in Real Clinical Practice: a Prospective Cohort Study
A real-world prospective cohort trial evaluating the effectiveness of a complex of carnitine orotate and biphenyl dimethyl dicarboxylate for…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial evaluating combination regimens including JNJ-73763989 and JNJ-56136379 for chronic hepatitis B; the study is completed and re…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 study evaluating two Janssen investigational agents (JNJ-73763989 and JNJ-56136379) in virologically suppressed adults with chronic …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders [Phase 4]
Phase 4 clinical trial update on the HepB-CpG vaccine series for healthcare workers who did not respond to hepatitis B vaccination; results …
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study [Phase 1, Phase 2]
A clinical trial update on HEC121120 examining tolerance in healthy subjects and adults with chronic hepatitis B, along with pharmacokinetic…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections [NA]
Update on the COIN-B trial evaluating controlled interruption of nucleoside analogue therapy in chronic hepatitis B; current status of the s…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection [Phase 2]
Phase 2 trial evaluating GLS4 in combination with ritonavir for chronic hepatitis B infection has been completed, assessing safety, tolerabi…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients [NA]
A clinical trial evaluating sequential therapy with a PD-1 antibody followed by Peg-IFNα in chronic hepatitis B patients; currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) [NA]
A clinical trial update indicates the TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) is currently recruiting. It…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
This clinical trial update reports a Phase 2 study by Brii Biosciences evaluating the safety and efficacy of BRII-835 and BRII-179 combinati…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
A clinical trial update announcing collection of blood from healthy individuals, patients with benign disease, and cancer patients sponsored…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B [Phase 1, Phase 2]
A Phase 1/2 clinical trial is planned to evaluate the efficacy of TQA3038 Injection for chronic hepatitis B, with status not yet recruiting.
-
EMA approval · 2024-06-07EMA Authorised: Lamivudine Teva (lamivudine) — Teva B.V.
The EMA authorised Lamivudine Teva (lamivudine) for chronic hepatitis B. Teva B.V. is the marketing authorisation holder.